MetLife Investment Management’s CoreCard CCRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,475
Closed -$93.5K 2821
2025
Q3
$93.5K Hold
3,475
﹤0.01% 2677
2025
Q2
$101K Buy
+3,475
New +$81.5K ﹤0.01% 2534
2023
Q4
Sell
-3,852
Closed -$77K 2835
2023
Q3
$77K Hold
3,852
﹤0.01% 2716
2023
Q2
$97.7K Buy
+3,852
New +$99.4K ﹤0.01% 2693
2022
Q2
Sell
-4,109
Closed -$113K 2867
2022
Q1
$113K Buy
4,109
+1,492
+57% +$50.7K ﹤0.01% 2601
2021
Q4
$102K Hold
2,617
﹤0.01% 2400
2021
Q3
$106K Buy
+2,617
New +$93.2K ﹤0.01% 2420
2021
Q1
Sell
-3,124
Closed -$125K 2317
2020
Q4
$125K Hold
3,124
﹤0.01% 2197
2020
Q3
$122K Hold
3,124
﹤0.01% 2121
2020
Q2
$106K Hold
3,124
﹤0.01% 2227
2020
Q1
$106K Hold
3,124
﹤0.01% 2041
2019
Q4
$125K Hold
3,124
﹤0.01% 2213
2019
Q3
$130K Buy
+3,124
New +$140K ﹤0.01% 2188

MetLife Investment Management's CCRD Position: Q4 2025 in Review

MetLife Investment Management sold out of CoreCard (CCRD) in Q4 2025, closing a stake of 3,475 shares — an estimated $93.5K sold.

MetLife Investment Management first reported a position in CCRD in Q3 2019 and held it in 13 quarters. The position peaked at $130K in Q3 2019. 0 funds tracked by Wall St. Rank hold CCRD as of Q4 2025.

  • MetLife Investment Management reported no remaining CoreCard position as of Q4 2025 after selling out during the quarter.
  • MetLife Investment Management sold 3,475 CoreCard shares in Q4 2025, an estimated $93.5K.
  • MetLife Investment Management first reported a position in CoreCard in Q3 2019 and held it in 13 quarters.
  • MetLife Investment Management's CoreCard position peaked at $130K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held CoreCard as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.